Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 2
2005 8
2006 6
2007 6
2008 6
2009 10
2010 5
2011 6
2012 4
2013 7
2014 8
2015 10
2016 6
2017 16
2018 12
2019 10
2020 14
2021 10
2022 9
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean young lee shin (1 results)?
c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer.
Park J, Chang ES, Kim JY, Chelakkot C, Sung M, Song JY, Jung K, Lee JH, Choi JY, Kim NY, Lee H, Kang MR, Kwon MJ, Shin YK, Park YH, Choi YL. Park J, et al. Among authors: shin yk. Breast Cancer Res. 2024 Jan 18;26(1):13. doi: 10.1186/s13058-024-01768-y. Breast Cancer Res. 2024. PMID: 38238761 Free PMC article.
Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer.
Fujiki Y, Kashiwaba M, Sato M, Kawano J, Teraoka M, Kanemitsu S, Rai Y, Taira T, Sagara Y, Ohi Y, Jo U, Lee YW, Lee SB, Gong G, Shin YK, Kwon MJ, Sagara Y. Fujiki Y, et al. Among authors: shin yk. Breast Cancer. 2024 Jan;31(1):31-41. doi: 10.1007/s12282-023-01509-7. Epub 2023 Oct 9. Breast Cancer. 2024. PMID: 37812303 Free PMC article.
10 years of biologic use patterns in patients with inflammatory bowel disease: treatment persistence, switching and dose intensification - a nationwide population-based study.
Koo HM, Jun YK, Choi Y, Shin CM, Park YS, Kim N, Lee DH, Shin YK, Yoon H. Koo HM, et al. Among authors: shin yk. Therap Adv Gastroenterol. 2023 Sep 29;16:17562848231201728. doi: 10.1177/17562848231201728. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 37786473 Free PMC article.
Oxygen-independent stabilization of HIF-2α in breast cancer through direct interaction with peptidyl-prolyl cis-trans isomerase NIMA-interacting 1.
Guillen-Quispe YN, Kim SJ, Saeidi S, Zhou T, Zheng J, Kim SH, Fang X, Chelakkot C, Rios-Castillo ME, Shin YK, Surh YJ. Guillen-Quispe YN, et al. Among authors: shin yk. Free Radic Biol Med. 2023 Oct;207:296-307. doi: 10.1016/j.freeradbiomed.2023.07.020. Epub 2023 Jul 19. Free Radic Biol Med. 2023. PMID: 37473874
RGS2-mediated translational control mediates cancer cell dormancy and tumor relapse.
Cho J, Min HY, Lee HJ, Hyun SY, Sim JY, Noh M, Hwang SJ, Park SH, Boo HJ, Lee HJ, Hong S, Park RW, Shin YK, Hung MC, Lee HY. Cho J, et al. Among authors: shin yk. J Clin Invest. 2023 May 15;133(10):e171901. doi: 10.1172/JCI171901. J Clin Invest. 2023. PMID: 37183821 Free PMC article. No abstract available.
Pretreatment of rhesus monkeys with transdermal patches containing physostigmine and procyclidine: implications of the delivery system for the potential application against VX nerve agent intoxication in humans.
Nam JH, Kim MS, Song YJ, Kim CH, Kim WS, Yu CH, Joe HE, Hur GH, Seo MR, Kim Y, Park KE, Choi JY, Chung SJ, Shin YK. Nam JH, et al. Among authors: shin yk. Arch Toxicol. 2023 Mar;97(3):697-710. doi: 10.1007/s00204-022-03438-4. Epub 2023 Jan 12. Arch Toxicol. 2023. PMID: 36633609
151 results